These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 35694534)

  • 1. Elevated IP-10 at the Protein and Gene Level Associates With Pulmonary TB.
    Fisher KL; Moodley D; Rajkumar-Bhugeloo K; Baiyegunhi OO; Karim F; Ndlovu H; Ndung'u T; Marakalala MJ
    Front Cell Infect Microbiol; 2022; 12():908144. PubMed ID: 35694534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarkers for discrimination between latent tuberculosis infection and active tuberculosis disease.
    Won EJ; Choi JH; Cho YN; Jin HM; Kee HJ; Park YW; Kwon YS; Kee SJ
    J Infect; 2017 Mar; 74(3):281-293. PubMed ID: 27871809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IP-10 differentiates between active and latent tuberculosis irrespective of HIV status and declines during therapy.
    Wergeland I; Pullar N; Assmus J; Ueland T; Tonby K; Feruglio S; Kvale D; Damås JK; Aukrust P; Mollnes TE; Dyrhol-Riise AM
    J Infect; 2015 Apr; 70(4):381-91. PubMed ID: 25597826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiplex analysis of plasma cytokines/chemokines showing different immune responses in active TB patients, latent TB infection and healthy participants.
    Yao X; Liu Y; Liu Y; Liu W; Ye Z; Zheng C; Ge S
    Tuberculosis (Edinb); 2017 Dec; 107():88-94. PubMed ID: 29050777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mycobacteria-Specific Cytokine Responses Detect Tuberculosis Infection and Distinguish Latent from Active Tuberculosis.
    Tebruegge M; Dutta B; Donath S; Ritz N; Forbes B; Camacho-Badilla K; Clifford V; Zufferey C; Robins-Browne R; Hanekom W; Graham SM; Connell T; Curtis N
    Am J Respir Crit Care Med; 2015 Aug; 192(4):485-99. PubMed ID: 26030187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic performance of a cytokine and IFN-γ-induced chemokine mRNA assay after Mycobacterium tuberculosis-specific antigen stimulation in whole blood from infected individuals.
    Kim S; Lee H; Kim H; Kim Y; Cho JE; Jin H; Kim DY; Ha SJ; Kang YA; Cho SN; Lee H
    J Mol Diagn; 2015 Jan; 17(1):90-9. PubMed ID: 25528189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of inducible protein 10 as a biomarker for the diagnosis of tuberculosis.
    Hong JY; Jung GS; Kim H; Kim YM; Lee HJ; Cho SN; Kim SK; Chang J; Kang YA
    Int J Infect Dis; 2012 Dec; 16(12):e855-9. PubMed ID: 22959355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discrimination between active and latent tuberculosis based on ratio of antigen-specific to mitogen-induced IP-10 production.
    Jeong YH; Hur YG; Lee H; Kim S; Cho JE; Chang J; Shin SJ; Lee H; Kang YA; Cho SN; Ha SJ
    J Clin Microbiol; 2015 Feb; 53(2):504-10. PubMed ID: 25428147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic accuracy of interferon (IFN)-γ inducible protein 10 (IP-10) as a biomarker for the discrimination of active and latent tuberculosis.
    Mamishi S; Mahmoudi S; Banar M; Hosseinpour Sadeghi R; Marjani M; Pourakbari B
    Mol Biol Rep; 2019 Dec; 46(6):6263-6269. PubMed ID: 31564016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Host biomarkers other than interferon gamma in QFT-TB supernatants for identifying active tuberculosis.
    Zhou Y; Zhang F; Shi H; Wu P; Zhou Y
    Tuberculosis (Edinb); 2022 Sep; 136():102256. PubMed ID: 36113397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune responses to ESAT-6 and CFP-10 by FASCIA and multiplex technology for diagnosis of M. tuberculosis infection; IP-10 is a promising marker.
    Borgström E; Andersen P; Atterfelt F; Julander I; Källenius G; Maeurer M; Rosenkrands I; Widfeldt M; Bruchfeld J; Gaines H
    PLoS One; 2012; 7(11):e43438. PubMed ID: 23144772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple cytokine analysis based on QuantiFERON-TB gold plus in different tuberculosis infection status: an exploratory study.
    Zhang L; Yang Z; Wu F; Ge Q; Zhang Y; Li D; Gao M; Liu X
    BMC Infect Dis; 2024 Jan; 24(1):28. PubMed ID: 38166667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression of host protein biomarkers among symptomatic clinic attendees finally diagnosed with tuberculosis and other respiratory diseases with or without latent Mycobacterium tuberculosis infection.
    Namuganga AR; Nsereko M; Bagaya BS; Mayanja-Kizza H; Chegou NN
    Immunol Lett; 2023 Jan; 253():8-18. PubMed ID: 36463987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Use of Interferon Gamma Inducible Protein 10 as a Potential Biomarker in the Diagnosis of Latent Tuberculosis Infection in Uganda.
    Biraro IA; Kimuda S; Egesa M; Cose S; Webb EL; Joloba M; Smith SG; Elliott AM; Dockrell HM; Katamba A
    PLoS One; 2016; 11(1):e0146098. PubMed ID: 26771653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between DNA Methylation Profiles and Active Tuberculosis Development from Latent Infection: a Pilot Study in Nested Case-Control Design.
    Du Y; Gao X; Yan J; Zhang H; Cao X; Feng B; He Y; He Y; Guo T; Xin H; Gao L
    Microbiol Spectr; 2022 Jun; 10(3):e0058622. PubMed ID: 35446152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of candidate host serum and saliva biomarkers for a better diagnosis of active and latent tuberculosis infection.
    Estévez O; Anibarro L; Garet E; Pallares Á; Pena A; Villaverde C; Del Campo V; González-Fernández Á
    PLoS One; 2020; 15(7):e0235859. PubMed ID: 32687494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gaps in Study Design for Immune Parameter Research for Latent Tuberculosis Infection: A Systematic Review.
    Herrera M; Vera C; Keynan Y; Rueda ZV
    J Immunol Res; 2020; 2020():8074183. PubMed ID: 32377537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjunctive biomarkers for improving diagnosis of tuberculosis and monitoring therapeutic effects.
    Hur YG; Kang YA; Jang SH; Hong JY; Kim A; Lee SA; Kim Y; Cho SN
    J Infect; 2015 Apr; 70(4):346-55. PubMed ID: 25452040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of IL-2, IL-10, IL-17 and IP-10 as potent discriminative markers for active tuberculosis among pulmonary tuberculosis suspects.
    You E; Kim MH; Lee WI; Kang SY
    Tuberculosis (Edinb); 2016 Jul; 99():100-108. PubMed ID: 27450011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokine biomarkers for the diagnosis of tuberculosis infection and disease in adults in a low prevalence setting.
    Clifford V; Tebruegge M; Zufferey C; Germano S; Forbes B; Cosentino L; Matchett E; McBryde E; Eisen D; Robins-Browne R; Street A; Denholm J; Curtis N
    Tuberculosis (Edinb); 2019 Jan; 114():91-102. PubMed ID: 30711163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.